CURA STRATEGIES for PKD FOUNDATION
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Health Issues HCR
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Defense DEF
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.